Efficacy and safety of statin therapy in children with familial hypercholesterolemia: A randomized controlled trial

JAMA

Volumn 292, Issue 3, 2004, Pages 331-337

  Wiegman, Albert ^a   Hutten, Barbara A ^a   De Groot, Eric ^a   Rodenburg, Jessica ^a   Bakker, Henk D ^a   Büller, Harry R ^a   Sijbrands, Eric J G ^a,b   Kastelein, John J P ^a,c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; CORTICOTROPIN; CREATINE KINASE; ESTRADIOL; FOLLITROPIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HORMONE; HYDROCORTISONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; LIPID; LIPOPROTEIN; LIPOPROTEIN A; LIVER ENZYME; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; LUTEINIZING HORMONE; PRASTERONE SULFATE; PRAVASTATIN; TESTOSTERONE; THYROTROPIN; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; ATHEROSCLEROSIS; B SCAN; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; FOLLOW UP; GENE MUTATION; GROWTH; HUMAN; LIVER; MAJOR CLINICAL STUDY; MALE; MUSCLE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEXUAL MATURATION; BLOOD; CAROTID ARTERY DISEASE; ECHOGRAPHY; HYPERLIPOPROTEINEMIA TYPE 2; PROSPECTIVE STUDY;

ADOLESCENT; CAROTID ARTERY DISEASES; CHILD; CHOLESTEROL, LDL; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPOPROTEINEMIA TYPE II; MALE; PRAVASTATIN; PROSPECTIVE STUDIES;

EID: 3142717531     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.292.3.331     Document Type: Article

References (26)

1. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Natural history of aortic and coronary atherosclerotic lesions in youth: findings from the PDAY Study. Arterioscler Thromb. 1993;13:1291-1298.
2. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking. JAMA. 1990;264:3018-3024.
3. Kwiterovich PO Jr, Frederickson DS, Levi RI. Neonatal diagnosis of familial type-II hyperlipoproteinemia. Lancet 1973;1:118-121.
4. Kwiterovich PO Jr, Fredrickson DS, Levy RI. Familial hypercholesterolemia (one form of familial type II hyperlipoproteinemia): a study of its biochemical, genetic, and clinical presentation in childhood. J Clin Invest. 1974;53:1237-1249.
5. De Jongh S, Lilien MR, Bakker HD, Hutten BA, Kastelein JJP, Stroes ESG. Family history of cardiovascular events and endothelial dysfunction in children with familial hypercholesterolemia. Atherosclerosis. 2002;163:193-197.
6. Pauciullo P, Iannuzzi A, Sartorio R, et al. Increased intima-media thickness of the common carotid artery in hypercholesterolemic children. Arterioscler Thromb. 1994;14:1075-1079.
7. Tonstad S, Joakimson O, Stensland-Bugge E, et al. Risk factors related to intima-media thickness in children with familial hypercholesterolemia and control subjects. Arterioscler Thromb Vasc Biol. 1996;16:984-991.
8. Jarvisalo MJ, Jartti L, Nanto-Salonen K, et al. Increased aortic intima-media thickness: a marker of preclinical atherosclerosis in high-risk children. Circulation. 2001;104:2943-2947.
9. Wiegman A, De Groot E, Hutten BA, et al. Arterial intima-media thickness in children heterozygous for familial hypercholesterolemia. Lancet. 2004;363:369-370.
10. Mabuchi H, Koizumi J, Shimizu M, Takeda R; Hokuriky FH-CHD Study Group. Development of coronary heart disease in familial hypercholesterolemia. Circulation. 1989;79:225-232.
11. Mouratidis B, Vaughan-Neil EF, Gilday DL, et al. Detection of silent coronary artery disease in adolescents and young adults with familial hypercholesterolemia by single-photon emission computed tomography thallium-201 scanning. Am J Cardiol. 1992;70:1109-1112.
12. Knipscheer HC, Boelen CCA, Kastelein JJP, et al. Short-term efficacy and safety of pravastatin in 72 children with familial hypercholesterolemia. Pediatr Res. 1996;39:867-871.
13. Lambert M, Lupien PJ, Cagne C, et al; Canadian Lovastatin in Children Study Group. Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Pediatrics. 1996;97:619-628.
14. Stein EA, Illingworth DR, Kwiterovich PO Jr, et al. Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial. JAMA. 1999;281:137-144.
15. De Jongh S, Ose L, Szamosi T, et al. Efficacy and safety of statin therapy in children with familial hypercholesterolemia. Circulation. 2002;106:2231-2237.
16. De Jongh S, Lilien MR, Op't Roodt J, Stroes ES, Bakker HD, Kastelein JJP. Early statin therapy restores endothelial function in children with familial hypercholesterolemia. J Am Coll Cardiol. 2002;40:2117-2121.
17. O'Leary DH, Polak JF, Kronwal RA, Manolio TA, Burke GL, Wolfson SK. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med. 1999;340:14-22.
18. Hodis HN, Mack WJ, LaBree L, et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med. 1998;128:262-269.
19. Chambless LE, Heiss G, Folsom AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol. 1997;146:483-494.
20. Wiegman A, Rodenburg J, de Jongh S, et al. Family history and cardiovascular risk in familial hypercholesterolemia: data in more than 1000 children. Circulation. 2003;107:1473-1478.
21. Voedingsraad. Nederlandse Voedingsnormen 1989. 2nd ed. The Hague, the Netherlands: Voedingsraad; 1992.
22. Voedingscentrum. Zo eet Nederland, resultaten van de Voedselconsumptiepeiling 1998. 3rd ed. The Hague, the Netherlands: Voedingscentrum; 1998.
23. Van Dam M, de Groot E, Clee SM, et al. Association between increased arterial wall thickness and impairment in ABCA1 driven cholesterol efflux; an observational study. Lancet 2002;359:37-41.
24. Warnick GR, Knopp RH, Fitzpatrick V, Branson L. Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints. Clin Chem. 1990;36:15-19.
25. Fouchier SW, Defesche JC, Umans-Eckenhausen MAW, Kastelein JJP. The molecular basis of familial hypercholesterolemia in the Netherlands. Hum Genet. 2001;109:602-615.
26. Haycock GB, Schwartz GJ, Wisotsky DH. Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults. J Pediatr. 1978;93:62-66.